(-)-Thalidomide,
(S)-Thalidomide,
l-Thalidomide,
Thalidomide, L-,
S-(-)-Thalidomide,
841-67-8,
S-Thalidomide,
(S)-(-)-thalidomide,
UNII-TG87FSR590,
NSC 91730,
TG87FSR590,
CHEBI:61918,
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, (-)-,
Phthalimide, N-(2,6-dioxo-3-piperidyl)-, L-(-)-,
2-[(3S)-2,6-dioxopiperidin-3-yl]-1H-isoindole-1,3(2H)-dione,
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-, (S)-,
(?)-Thalidomide,
SMR000857221,
CAS-50-35-1,
EF2,
Thalidomide, (-)-,
Tocris-0652,
4ci1,
Lopac-T-144,
AC1L3NIA,
AC1Q6NYH,
MLS001333073,
MLS001333074,
SCHEMBL455269,
CHEMBL426123,
DTXSID1046972,
BDBM65457,
HMS2230K15,
(-)-Thalidomide, >98%, solid,
ZINC1530947,
API0000112,
FCH3609445,
NCGC00015989-01,
NCGC00015989-02,
NCGC00016220-01,
NCGC00024708-01,
AJ-26714,
CJ-05220,
CJ-24061,
LS-109465,
A828082,
(S)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione,
2-[(3S)-2,6-dioxo-3-piperidinyl]isoindole-1,3-dione,
2-[(3S)-2,6-dioxopiperidin-3-yl]isoindole-1,3-dione,
UNII-4Z8R6ORS6L component UEJJHQNACJXSKW-VIFPVBQESA-N,
2-[(3S)-2,6-bis(oxidanylidene)piperidin-3-yl]isoindole-1,3-dione,
S(-)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione,
(S)-(-)-2-(2,6-Dioxo-3-piperidinyl)-1H-iso-indole-1,3(2H)-dione,
thalidomide,
Thalidomide, (S)-,
-THALIDOMIDE,
S)-(-)-Thalidomide,
CID92142,
AR-1L6638,
C13-H10-N2-O4,
A10924,
50-35-1,
899-55-8,